Agenda
11:00 AM — 12:00 PM
Addressing Heterogeneity of Real World Evidence in Drug Safety11:00 AM — 12:00 PM
Moving Forward in EU Pharmacovigilance2:15 PM — 3:15 PM
Interpretation of New Pharmacovigilance Regulations: Key Insights10:30 AM — 11:30 AM
An Industry Collaboration on Pharmacovigilance Analytics10:30 AM — 11:30 AM
Emerging Safety Challenges in New Oncology Treatments3:30 PM — 4:00 PM
8:00 AM — 9:15 AM
So Much Data, So Little Time: Hot Topics in Benefit-Risk Assessment8:00 AM — 9:15 AM
Triple-s (3S) Smart Safety Surveillance10:30 AM — 11:30 AM
Digital Risk Minimization: The “Next Generation” Risk Management Tools4:15 PM — 5:30 PM
From Trials to Real World: How Safety Protocols Impact REMS9:00 AM — 10:15 AM
Successes and Challenges in Pharmacovigilance for Biologics and BiosimilarsHave an account?